Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition

Abstract Background Medulloblastoma (MB) is a malignant tumour of the cerebellum which can be classified into four major subgroups based on gene expression and genomic features. Single-cell transcriptome studies have defined the cellular states underlying each MB subgroup; however, the spatial organ...

Full description

Bibliographic Details
Main Authors: Tuan Vo, Brad Balderson, Kahli Jones, Guiyan Ni, Joanna Crawford, Amanda Millar, Elissa Tolson, Matthew Singleton, Marija Kojic, Thomas Robertson, Shaun Walters, Onkar Mulay, Dharmesh D. Bhuva, Melissa J. Davis, Brandon J. Wainwright, Quan Nguyen, Laura A. Genovesi
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Genome Medicine
Subjects:
Online Access:https://doi.org/10.1186/s13073-023-01185-4
_version_ 1797822740400439296
author Tuan Vo
Brad Balderson
Kahli Jones
Guiyan Ni
Joanna Crawford
Amanda Millar
Elissa Tolson
Matthew Singleton
Marija Kojic
Thomas Robertson
Shaun Walters
Onkar Mulay
Dharmesh D. Bhuva
Melissa J. Davis
Brandon J. Wainwright
Quan Nguyen
Laura A. Genovesi
author_facet Tuan Vo
Brad Balderson
Kahli Jones
Guiyan Ni
Joanna Crawford
Amanda Millar
Elissa Tolson
Matthew Singleton
Marija Kojic
Thomas Robertson
Shaun Walters
Onkar Mulay
Dharmesh D. Bhuva
Melissa J. Davis
Brandon J. Wainwright
Quan Nguyen
Laura A. Genovesi
author_sort Tuan Vo
collection DOAJ
description Abstract Background Medulloblastoma (MB) is a malignant tumour of the cerebellum which can be classified into four major subgroups based on gene expression and genomic features. Single-cell transcriptome studies have defined the cellular states underlying each MB subgroup; however, the spatial organisation of these diverse cell states and how this impacts response to therapy remains to be determined. Methods Here, we used spatially resolved transcriptomics to define the cellular diversity within a sonic hedgehog (SHH) patient-derived model of MB and show that cells specific to a transcriptional state or spatial location are pivotal for CDK4/6 inhibitor, Palbociclib, treatment response. We integrated spatial gene expression with histological annotation and single-cell gene expression data from MB, developing an analysis strategy to spatially map cell type responses within the hybrid system of human and mouse cells and their interface within an intact brain tumour section. Results We distinguish neoplastic and non-neoplastic cells within tumours and from the surrounding cerebellar tissue, further refining pathological annotation. We identify a regional response to Palbociclib, with reduced proliferation and induced neuronal differentiation in both treated tumours. Additionally, we resolve at a cellular resolution a distinct tumour interface where the tumour contacts neighbouring mouse brain tissue consisting of abundant astrocytes and microglia and continues to proliferate despite Palbociclib treatment. Conclusions Our data highlight the power of using spatial transcriptomics to characterise the response of a tumour to a targeted therapy and provide further insights into the molecular and cellular basis underlying the response and resistance to CDK4/6 inhibitors in SHH MB.
first_indexed 2024-03-13T10:13:38Z
format Article
id doaj.art-7b01e6e8430f4272932f8e0c58f61003
institution Directory Open Access Journal
issn 1756-994X
language English
last_indexed 2024-03-13T10:13:38Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Genome Medicine
spelling doaj.art-7b01e6e8430f4272932f8e0c58f610032023-05-21T11:22:26ZengBMCGenome Medicine1756-994X2023-05-0115112810.1186/s13073-023-01185-4Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibitionTuan Vo0Brad Balderson1Kahli Jones2Guiyan Ni3Joanna Crawford4Amanda Millar5Elissa Tolson6Matthew Singleton7Marija Kojic8Thomas Robertson9Shaun Walters10Onkar Mulay11Dharmesh D. Bhuva12Melissa J. Davis13Brandon J. Wainwright14Quan Nguyen15Laura A. Genovesi16Institute for Molecular Bioscience, The University of QueenslandInstitute for Molecular Bioscience, The University of QueenslandInstitute for Molecular Bioscience, The University of QueenslandInstitute for Molecular Bioscience, The University of QueenslandInstitute for Molecular Bioscience, The University of QueenslandThe University of Queensland Frazer Institute, Translational Research InstituteThe University of Queensland Frazer Institute, Translational Research InstituteThe University of Queensland Frazer Institute, Translational Research InstituteThe University of Queensland Frazer Institute, Translational Research InstituteDepartment of Pathology, Royal Brisbane and Women’s Hospital, University of QueenslandSchool of Biomedical Sciences, The University of QueenslandInstitute for Molecular Bioscience, The University of QueenslandBioinformatics Division, The Walter and Eliza Hall Institute of Medical ResearchThe University of Queensland Frazer Institute, Translational Research InstituteThe University of Queensland Frazer Institute, Translational Research InstituteInstitute for Molecular Bioscience, The University of QueenslandInstitute for Molecular Bioscience, The University of QueenslandAbstract Background Medulloblastoma (MB) is a malignant tumour of the cerebellum which can be classified into four major subgroups based on gene expression and genomic features. Single-cell transcriptome studies have defined the cellular states underlying each MB subgroup; however, the spatial organisation of these diverse cell states and how this impacts response to therapy remains to be determined. Methods Here, we used spatially resolved transcriptomics to define the cellular diversity within a sonic hedgehog (SHH) patient-derived model of MB and show that cells specific to a transcriptional state or spatial location are pivotal for CDK4/6 inhibitor, Palbociclib, treatment response. We integrated spatial gene expression with histological annotation and single-cell gene expression data from MB, developing an analysis strategy to spatially map cell type responses within the hybrid system of human and mouse cells and their interface within an intact brain tumour section. Results We distinguish neoplastic and non-neoplastic cells within tumours and from the surrounding cerebellar tissue, further refining pathological annotation. We identify a regional response to Palbociclib, with reduced proliferation and induced neuronal differentiation in both treated tumours. Additionally, we resolve at a cellular resolution a distinct tumour interface where the tumour contacts neighbouring mouse brain tissue consisting of abundant astrocytes and microglia and continues to proliferate despite Palbociclib treatment. Conclusions Our data highlight the power of using spatial transcriptomics to characterise the response of a tumour to a targeted therapy and provide further insights into the molecular and cellular basis underlying the response and resistance to CDK4/6 inhibitors in SHH MB.https://doi.org/10.1186/s13073-023-01185-4MedulloblastomaSpatial transcriptomicsVisiumPalbociclibCDK4/6 inhibitorNeuron differentiation
spellingShingle Tuan Vo
Brad Balderson
Kahli Jones
Guiyan Ni
Joanna Crawford
Amanda Millar
Elissa Tolson
Matthew Singleton
Marija Kojic
Thomas Robertson
Shaun Walters
Onkar Mulay
Dharmesh D. Bhuva
Melissa J. Davis
Brandon J. Wainwright
Quan Nguyen
Laura A. Genovesi
Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition
Genome Medicine
Medulloblastoma
Spatial transcriptomics
Visium
Palbociclib
CDK4/6 inhibitor
Neuron differentiation
title Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition
title_full Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition
title_fullStr Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition
title_full_unstemmed Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition
title_short Spatial transcriptomic analysis of Sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition
title_sort spatial transcriptomic analysis of sonic hedgehog medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to cdk4 6 inhibition
topic Medulloblastoma
Spatial transcriptomics
Visium
Palbociclib
CDK4/6 inhibitor
Neuron differentiation
url https://doi.org/10.1186/s13073-023-01185-4
work_keys_str_mv AT tuanvo spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT bradbalderson spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT kahlijones spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT guiyanni spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT joannacrawford spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT amandamillar spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT elissatolson spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT matthewsingleton spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT marijakojic spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT thomasrobertson spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT shaunwalters spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT onkarmulay spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT dharmeshdbhuva spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT melissajdavis spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT brandonjwainwright spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT quannguyen spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition
AT lauraagenovesi spatialtranscriptomicanalysisofsonichedgehogmedulloblastomaidentifiesthatthelossofheterogeneityandpromotionofdifferentiationunderliestheresponsetocdk46inhibition